Preprocedural Cross-Sectional Imaging Prior to Percutaneous Peripheral Arterial Disease Interventions

Abstract

Preprocedural cross-sectional imaging (PCSI) for peripheral artery disease (PAD) may vary due to patient complexity, anatomical disease burden, and physician preference. The objective of this study was to determine the utility of PCSI prior to percutaneous vascular interventions (PVIs) for PAD. Patients receiving first time lower extremity angiograms from 2013 to 2015 at a single institution were evaluated for PCSI performed within 180 days, defined as computed tomography angiography (CTA) or magnetic resonance angiography (MRA) evaluating abdominal to pedal vasculature. The primary outcome was technical success defined as improving the target outflow vessels to <30% stenosis. Of the 346 patients who underwent lower extremity angiograms, 158 (45.7%) patients had PCSI, including 150 patients had CTA and 8 patients had MRA. Of these, 48% were ordered by the referring provider (84% at an outside institution). Preprocedural cross-sectional imaging was performed at a median of 26 days (interquartile range: 9-53) prior to the procedure. The analysis of the institution’s 5 vascular surgeons identified PCSI rates ranging from 31% to 70%. On multivariate analysis, chronic kidney disease (odds ratio [OR] = 0.35; 95% confidence interval [CI]: 0.17-0.73) was associated with less PSCI usage, and inpatient/emergency department evaluation (OR = 3.20; 95% CI: 1.58-6.50) and aortoiliac disease (OR = 2.78; 95% CI: 1.46-5.29) were associated with higher usage. After excluding 31 diagnostic procedures, technical success was not statistically significant with PSCI (91.3%) compared to without PCSI (85.6%), P = .11. When analyzing 89 femoral–popliteal occlusions, technical success was higher with PCSI (88%) compared to procedures without (69%) P = .026. Our analysis demonstrates that routine ordering of PCSI may not be warranted when considering technical success of PVI; however, PCSI may be helpful in treatment planning. Further studies are needed to confirm these findings in another practice setting, with more prescriptive use of PCSI to improve procedural success, and thereby improve the value of PCSI.

Keywords

CT angiography MRA peripheral artery disease preoperative imaging

Get full access to this article

View all access options for this article.

References

Berwick

Hackbarth

. Eliminating waste in US health care. JAMA. 2012;307(14):1513–1516.

Bentley

TGK

Effros

Palar

Keeler

. Waste in the U.S. healthcare system: a conceptual framework. Milbank Q. 2008;86(4):629–659.

De Vos

Bol

Gravereaux

Hamming

Nguyen

. Treatment planning for peripheral arterial disease based on duplex ultrasonography and computed tomography angiography: consistency, confidence and the value of additional imaging. Surgery. 2014;156(2):492–502.

Von Ziegler

Costa

. The role of CT and MRI in the assessment of peripheral vascular disease. Curr Cardiol Rep. 2007;9(5):412–419.

Schernthaner

Fleischmann

Stadler

Schernthaner

Lammer

Loewe

. Value of MDCT angiography in developing treatment strategies for critical limb ischemia. AJR Am J Roentgenol. 2009;192(5):1416–1424.

Shue

Damle

Flahive

, et al. The increased use of computed tomography angiography and magnetic resonance angiography as the sole imaging modalities prior to infrainguinal bypass has had no effect on outcomes. Ann Vasc Surg. 2015;29(6):1245–1254.

Conte

Pomposelli

Clair

, et al. Society for vascular surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. J Vasc Surg. 2015;61(Suppl. 3):2S–41S.

Gerhard-Herman

Gornik

Barrett

, et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation. 2017;69(11):1465–1508.

Aboyans

Ricco

Bartelink

MLEL

, et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the european society for vascular surgery (ESVS). Eur Heart J. 2018;39(9):763–816.

10.

Stoner

Calligaro

Chaer

, et al. Reporting standards of the society for vascular surgery for endovascular treatment of chronic lower extremity peripheral artery disease. J Vasc Surg. 2016;64(1):e1–e21.

11.

Diehm

Pattynama

Jaff

, et al. Clinical endpoints in peripheral endovascular revascularization trials: a case for standardized definitions. Eur J Vasc Endovasc Surg. 2008;36(4):409–419.

12.

Kang

Lee

Choi

, et al. Semiquantitative assessment of tibial artery calcification by computed tomography angiography and its ability to predict infrapopliteal angioplasty outcomes. J Vasc Surg. 2016;64(5):1335–1343.

13.

Itoga

Kim

Sailer

, et al. Lower extremity computed tomography angiography can help predict technical success of endovascular revascularization in the superficial femoral and popliteal artery. J Vasc Surg. 2017;66(3):835–843.e1.

14.

Hendee

O’Connor

. Radiation risks of medical imaging: separating fact from fantasy. Radiol. 2012;264(2):312–321.

15.

Aiello

Durgin

Daniel

, et al. Surgeon leadership in the coding, billing, and contractual negotiations for fenestrated endovascular aortic aneurysm repair increases medical center contribution margin and physician reimbursement. J Vasc Surg. 2017;66(4):997–1006.